Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Knowing when to start retirement accounts is essential for financial security. Take action now to ensure a comfortable retirement.
14,534 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
C3.ai has faced a dramatic 2026 drop, leaving investors wondering if the stock is a hidden bargain or a value trap. T...
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
A bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
Cloud giants and AI pioneers are driving a wave of data-center investment. We break down three stock picks that could...
Autonomous AI agents are moving beyond chatbots to do complex tasks. This article explains why the agentic market cou...
March is a pivotal time for industrial stocks as infrastructure and defense themes collide with energy transition dem...
A quiet shift in the job market is reshaping housing and lending. This piece breaks down how the white-collar recessi...
A practical guide to interpreting Champions Oncology earnings. We break down the numbers, trends, and what to watch n...
Investing in today’s AI-powered era means spotting durable winners. This guide explains how to identify a meet monste...
A sizable $12 million stake in a floor-and-decor retailer arrives as the stock trades off. This article breaks down t...
Two powerhouse energy stocks could shape the next decade. This guide explains why NextEra Energy and GE Vernova fit a...